Delisting of Securities from The Nasdaq Stock Market

Rhea-AI Summary

Nasdaq (NDAQ) announced on November 7, 2025 that it will delist multiple issuers whose securities have been suspended and not traded on Nasdaq for extended periods. Affected issuers include Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings (common stock and warrants), LakeShore Biopharma (ordinary shares and warrants), Shineco, Office Properties Income Trust (common shares of beneficial interest and 6.375% senior notes due 2050), Bollinger Innovations, Spring Valley Acquisition Corp II (Class A shares, warrants, units, and rights), and FlexShopper.

The notice cites the prior suspension dates for each issuer, ranging from April 15, 2025 through October 23, 2025, and references Nasdaq Rule 5800 Series governing delisting.

Positive

• Nasdaq provides clear timeline for delisting actions dated Nov 7, 2025
• Investors receive definitive status on suspended securities and trading halts

Negative

• Phoenix Motor common stock suspended on Apr 15, 2025
• Petros Pharmaceuticals common stock suspended on May 22, 2025
• Longevity Health Holdings common stock and warrants suspended on Sep 12, 2025
• LakeShore Biopharma ordinary shares and warrants suspended on Sep 22, 2025
• Office Properties Income Trust common shares and 6.375% senior notes suspended on Oct 7, 2025
• Spring Valley Acquisition Corp II Class A shares, warrants, units, rights suspended on Oct 21, 2025

News Market Reaction

+0.66%

1 alert

+0.66% News Effect

On the day this news was published, NDAQ gained 0.66%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Phoenix Motor Inc. Phoenix Motor Inc.’s common stock was suspended on April 15, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.’s common stock was suspended on May 22, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Femto Technologies Inc. Femto Technologies Inc.’s common stock was suspended on June 23, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Vaxart, Inc. Vaxart, Inc.’s common stock was suspended on July 8, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Wang & Lee Group, Inc. Wang & Lee Group, Inc.’s ordinary shares were suspended on August 26, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Longevity Health Holdings, Inc. Longevity Health Holdings, Inc.’s securities were suspended on September 12, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrants of LakeShore Biopharma Co, Ltd. LakeShore Biopharma Co., Ltd’s securities were suspended on September 22, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Shineco, Inc. Shineco, Inc.’s common stock was suspended on October 7, 2025 and has not traded on Nasdaq since that time

Nasdaq also announced today that it will delist the Common Shares of Beneficial Interest and 6.375% Senior Notes Due 2050 of Office Properties Income Trust. Office Properties Income Trust’s securities were suspended on October 7, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Bollinger Innovations, Inc. Bollinger Innovations, Inc.’s stock was suspended on October 13, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A Ordinary Shares, warrants, units, and rights of Spring Valley Acquisition Corp II. Spring Valley Acquisition Corp. II’s stock was suspended on October 21, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of FlexShopper, Inc. FlexShopper, Inc.’s common stock was suspended on October 23, 2025 and has not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

FAQ

What did Nasdaq announce about delistings on November 7, 2025 (NDAQ)?

Nasdaq announced it will delist multiple issuers whose securities have been suspended and not traded, listing the affected companies and suspension dates.

Which issuers will Nasdaq delist as of November 7, 2025?

Affected issuers include Phoenix Motor, Petros Pharmaceuticals, Femto Technologies, Vaxart, Wang & Lee Group, Longevity Health Holdings, LakeShore Biopharma, Shineco, Office Properties Income Trust, Bollinger Innovations, Spring Valley Acquisition Corp II, and FlexShopper.

When were Phoenix Motor and Petros Pharmaceuticals suspended from Nasdaq?

Phoenix Motor was suspended on Apr 15, 2025 and Petros Pharmaceuticals was suspended on May 22, 2025.

What Nasdaq rule governs the delisting process mentioned in the November 7, 2025 notice?

The delisting actions reference the Nasdaq Rule 5800 Series, available on Nasdaq's listing center rulebook.

Are Nasdaq senior notes affected in the November 7, 2025 delisting notice?

Yes; Office Properties Income Trust's 6.375% senior notes due 2050 are included among the securities Nasdaq will delist.

What suspension date range is cited for the delisted securities in the November 7, 2025 notice?

Suspension dates cited in the notice range from April 15, 2025 through October 23, 2025.